Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling.

SLAS technology·2019

Same author

Convergence of Three-Dimensional Cell Culture and Human iPS Cells: Improving Clinical Relevance in Drug Discovery.

SLAS technology·2019

Same author

Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization.

SLAS technology·2018

Same author

Three-Dimensional Cell Culture: A Rapidly Emerging Approach to Cellular Science and Drug Discovery.

SLAS discovery : advancing life sciences R & D·2017

Same author

Three-Dimensional Cell Cultures in Drug Discovery and Development.

SLAS discovery : advancing life sciences R & D·2017

Same author

Identifying orphan G protein coupled receptors in drug discovery.

Drug discovery today. Technologies·2014

Search research articles

Related Experiment Video

Updated: Apr 8, 2026

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?

Richard M Eglen¹, David H Randle¹

¹Corning Life Sciences , Tewksbury, Massachusetts.

Assay and Drug Development Technologies

|June 30, 2015

Summary

Three-dimensional (3D) cell culture offers more physiologically relevant models than traditional 2D methods for drug discovery. These advanced techniques improve compound screening and lead optimization, particularly in oncology.

More Related Videos

Generation of 3D Tumor Spheroids for Drug Evaluation Studies

Generation of 3D Tumor Spheroids for Drug Evaluation Studies

Published on: February 24, 2023

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Related Experiment Videos

Last Updated: Apr 8, 2026

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

Generation of 3D Tumor Spheroids for Drug Evaluation Studies

Generation of 3D Tumor Spheroids for Drug Evaluation Studies

Published on: February 24, 2023

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Area of Science:

Biotechnology
Cell Biology
Drug Discovery

Background:

Traditional two-dimensional (2D) cell cultures lack in vivo characteristics, contributing to high failure rates in clinical drug development.
Limitations of 2D cultures necessitate more physiologically relevant models for accurate compound screening and lead optimization.

Purpose of the Study:

To highlight the advancements and utility of three-dimensional (3D) cell culture techniques in modern drug discovery.
To emphasize the potential of 3D models, including organoids and spheroids, for high-throughput screening in oncology.

Main Methods:

Exploration of novel techniques in cell biology, materials science, and bioengineering for 3D cell culture.
Application of 3D culture systems, from simple spheroids to complex organoids, compatible with automation.
Integration of stem cells, such as induced pluripotent stem cells, into 3D models for enhanced phenotypic relevance.

Main Results:

3D culture methods provide more physiologically relevant cellular models compared to 2D cultures.
These advanced models are increasingly compatible with automation for high-throughput and high-content screening.
3D cultures, especially when incorporating stem cells, offer potential for disease-specific screening.

Conclusions:

Three-dimensional cell culture represents a significant advancement over 2D methods for drug discovery and development.
The adoption of 3D culture techniques, including organoids and spheroids, is crucial for improving the success rates of drug candidates, particularly in oncology.
Future applications may involve disease-specific screening using stem cell-derived 3D models.